Compare ALVO & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | OPRA |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | Luxembourg | Norway |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2021 | 2018 |
| Metric | ALVO | OPRA |
|---|---|---|
| Price | $4.29 | $14.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $7.50 | ★ $26.29 |
| AVG Volume (30 Days) | ★ 904.9K | 519.3K |
| Earning Date | 11-11-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 5.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.60 | $20.36 |
| Revenue Next Year | $22.47 | $15.27 |
| P/E Ratio | $18.20 | ★ $13.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $11.71 |
| 52 Week High | $6.53 | $20.78 |
| Indicator | ALVO | OPRA |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 33.64 |
| Support Level | $3.10 | $14.19 |
| Resistance Level | $4.59 | $19.02 |
| Average True Range (ATR) | 0.29 | 0.93 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 16.48 | 17.38 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.